Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Moderna
MRNA
|
$2.75B |
| 2 |
Coupang
CPNG
|
$1.09B |
| 3 |
Trade Desk
TTD
|
$793M |
| 4 |
BioNTech
BNTX
|
$736M |
| 5 |
Bilibili
BILI
|
$639M |
Top Sells
| 1 |
Tesla
TSLA
|
$7.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
$1.39B |
| 3 |
Meta Platforms (Facebook)
META
|
$880M |
| 4 |
Amazon
AMZN
|
$773M |
| 5 |
NIO
NIO
|
$619M |
Sector Composition
| 1 | Consumer Discretionary | 31.93% |
| 2 | Healthcare | 19.13% |
| 3 | Technology | 17.13% |
| 4 | Communication Services | 14.58% |
| 5 | Financials | 5.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Carvana
CVNA
$51.4B
| $1.64B | 0.92% | 6,236,566 +430,405 | +7% | +$113M |
|
27
Twilio
TWLO
$16.2B
| $1.62B | 0.91% | 4,749,577 +1,757,505 | +59% | +$599M |
|
28
Moody's
MCO
$91.4B
| $1.61B | 0.9% | 5,385,192 -41,131 | -0.8% | -$12.3M |
|
29
Microsoft
MSFT
$3.77T
| $1.61B | 0.9% | 6,817,737 -42,587 | -0.6% | -$10M |
|
|
ONC
30
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $1.54B | 0.86% | 4,428,715 +180,888 | +4% | +$63M |
|
31
Chegg
CHGG
$159M
| $1.54B | 0.86% | 17,930,195 +1,944,355 | +12% | +$167M |
|
32
Teladoc Health
TDOC
$1.37B
| $1.44B | 0.81% | 7,939,079 +700,412 | +10% | +$127M |
|
33
Alnylam Pharmaceuticals
ALNY
$58.5B
| $1.42B | 0.8% | 10,074,963 +942,541 | +10% | +$133M |
|
34
Elevance Health
ELV
$71.8B
| $1.41B | 0.79% | 3,924,086 -27,583 | -0.7% | -$9.9M |
|
35
Atlassian
TEAM
$46.6B
| $1.32B | 0.74% | 6,257,636 -319,166 | -5% | -$67.3M |
|
36
Martin Marietta Materials
MLM
$37.2B
| $1.27B | 0.71% | 3,786,796 +1,085,670 | +40% | +$365M |
|
37
Ryanair
RYAAY
$33.7B
| $1.19B | 0.67% | 10,373,329 -119,310 | -1% | -$13.7M |
|
38
Intuitive Surgical
ISRG
$170B
| $1.18B | 0.66% | 1,599,013 -311,464 | -16% | -$230M |
|
39
Roku
ROKU
$14.2B
| $1.18B | 0.66% | 3,609,008 +476,242 | +15% | +$155M |
|
40
NovoCure
NVCR
$1.38B
| $1.17B | 0.66% | 8,863,932 +602,857 | +7% | +$79.7M |
|
41
KE Holdings
BEKE
$20.8B
| $1.15B | 0.64% | 20,167,175 +2,535,744 | +14% | +$144M |
|
42
Salesforce
CRM
$245B
| $1.15B | 0.64% | 5,408,213 -206,524 | -4% | -$43.8M |
|
|
ABMD
43
DELISTED
Abiomed Inc
ABMD
| $1.1B | 0.61% | 3,442,328 +400,501 | +13% | +$128M |
|
|
44
Coupang
CPNG
$52.1B
| $1.09B | 0.61% | +22,054,023 | New | +$1.09B |
|
45
Zillow
Z
$20.4B
| $1B | 0.56% | 7,732,331 -12,835 | -0.2% | -$1.66M |
|
46
Arthur J. Gallagher & Co
AJG
$77.6B
| $988M | 0.55% | 7,919,140 -43,136 | -0.5% | -$5.38M |
|
47
Tencent Music
TME
$37.8B
| $943M | 0.53% | 46,032,615 +3,480,167 | +8% | +$71.3M |
|
48
CoStar Group
CSGP
$37.9B
| $943M | 0.53% | 1,147,435 +669,740 | +140% | +$550M |
|
49
Teradyne
TER
$18.8B
| $941M | 0.53% | 7,731,310 -174,993 | -2% | -$21.3M |
|
50
TSMC
TSM
$1.2T
| $923M | 0.52% | 7,799,336 -1,132,108 | -13% | -$134M |
|